On Tuesday, Shares of Intel Corporation (NASDAQ:INTC), gained 0.08% to $30.42.
Wind River, a wholly owned partner of Intel® Corporation (INTC), is a global leader in delivering software for the Internet of Things.
Wind River®, has introduced the latest version of Wind River Simics®. Simics accelerates software development by delivering ground-breaking development capabilities and facilitates Agile software practices through the use of simulation technologies.
The latest updates to Simics comprise accelerated simulation performance and expanded capabilities for enhancing access, collaboration, and automation for software developers. Additionally, the process for modeling, debugging, and model asset reuse has been further improved to deliver a simpler user experience. Other new improvements provide additional capabilities enabling Agile and automated testing with shorter feedback loops.
New features comprise the following:
- Greater performance: Simulation performance has been improved for tightly coupled multi-core and multiprocessor systems on multi-core hosts. Testing on parallel workloads shows performance enhances of up to seven times when simulating an eight-core Linux symmetric multiprocessing (SMP) target on an eight-core host. Coupled with its existing performance technologies, Simics can efficiently simulate ever more complex targets to deliver the benefits of simulation for any target system.
- Easier test automation: Simplified scripting interfaces and fault injection framework allow easier use of Simics in test automation environments.
- Simpler collaboration: A checkpoint server allows easier administration of checkpoints across teams. Users can share the system state of their simulations with others.
- Additional quick-start platforms: Immediate access to three quick-start platforms (Intel®, ARM®, and Power) allows every Simics user to enable early prototyping and tooling integration.
- Improved modeling support: Improved support for SystemC models with a new SystemC library and improved debugging tools assist teams get models up and running quickly.
Intel Corporation designs, manufactures, and sells integrated digital technology platforms worldwide. It operates through PC Client Group, Data Center Group, Internet of Things Group, Mobile and Communications Group, Software and Services, and All Other segments.
Shares of EnteroMedics Inc. (NASDAQ:ETRM), declined -36.08% to $0.62, during its last trading session, hitting its lowest level.
EnteroMedics Inc., declared the pricing of its formerly declared public offering of 40,229,886 units. Each unit comprises of one share of common stock, 0.50 of a Series A warrant to purchase one share of common stock, and 0.50 of a Series B warrant to purchase one share of common stock, at a purchase price of $0.87 per unit. Investors whose purchase of units in the offering would result in them beneficially owning more than the initial beneficial ownership limitation to be comprised of in the warrants following the consummation of the offering will have the opportunity to acquire units with Series C pre-funded warrants substituted for any common stock they would have otherwise attained over the initial beneficial ownership limitation, paying the same price of $0.87 per unit. The Series A warrants will be exercisable right away and will expire three years following issuance at an exercise price of $1.00 per share. The Series B warrants will be exercisable right away and will expire 12 months following issuance at an exercise price of $1.09 per share. The pre-funded Series C warrants will be exercisable right away and will expire five years following issuance.
Canaccord Genuity is acting as sole book-running manager and Craig-Hallum Capital Group is acting as co-manager for the offering. Northland Securities and Roth Capital Partners served as financial advisors to the Company in connection with this transaction.
The offering is predictable to close on or about July 6, 2015, subject to customary closing conditions counting, but not limited to, the receipt of all necessary regulatory approvals, counting the approvals of the NASDAQ Capital Market.
EnteroMedics Inc., a medical device company, focuses on the design and development of devices that use neuroblocking technology to treat obesity, metabolic diseases, and other gastrointestinal disorders. The company’s proprietary neuroblocking technology is designed to intermittently block the vagus nerve using electrical impulses.
Finally, Deere & Company (NYSE:DE), ended its last trade with 2.20% gain, and closed at $97.05, hitting its highest level.
Deere & Company, reiterated its support for Trade Promotion Authority legislation passed recently by the U.S. Senate after earlier approval by the U.S. House of Representatives. It now moves to U.S. President Barack Obama, who is predictable to sign the bill into law.
“We are happy this important trade bill has moved another step toward enactment,” said Samuel R. Allen, Deere & Company chairman and chief executive officer. “Trade Promotion Authority (TPA) strengthens the ability of the U.S. to advance a robust trade agenda that will expand jobs and opportunities for American businesses, farmers, and workers. This benefits our customers, our employees, and Deere’s business opportunities.”
TPA enables a U.S. President to submit projected trade agreement legislation to Congress for a yes or no vote, providing assurance to projected trading partners that the agreement will not be modified after negotiations have been accomplished.
Deere & Company, together with its auxiliaries, manufactures and distributes agriculture and turf, and construction and forestry equipment worldwide. The company’s Agriculture and Turf segment provides agriculture and turf equipment, and related service parts, counting large, medium, and utility tractors; loaders; combines, corn pickers, cotton and sugarcane harvesters, and related front-end equipment and sugarcane loaders; and tillage, seeding, and application equipment, counting sprayers, nutrient administration, and soil preparation machinery.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
